Dangerously low blood glucose levels in diabetics can be fatal for heart

Image
ANI Washington
Last Updated : Dec 13 2014 | 10:45 AM IST

A new study has confirmed an association between hypoglycaemia and an increased risk of cardiovascular events and mortality in insulin-treated patients with diabetes.

Scientists from the University of Leicester demonstrated that, following hypoglycaemia, insulin-treated patients with diabetes had a 60 percent higher risk of cardiovascular events and were between 2-2.5 times more likely to die over the same period as patients who did not experience hypoglycaemia.

Researcher Kamlesh Khunti, who led the research, said that this is one of the first studies to report the risk of cardiovascular events and mortality in people with both type 1 and type 2 diabetes. The risks are very significant and people need to identify these patients early with a view to implementing strategies to reduce their risk of hypoglycaemia.

Patients with diabetes are at higher risk of cardiovascular disease due to the formation of atherosclerotic plaques in blood vessels, which is a major cause of early death in these patients, and the results of the study show that hypoglycaemia, which occurs when a patient's blood glucose becomes dangerously low, can trigger potentially fatal cardiovascular events.

Researcher Melanie Davies commented that the data from this important and large piece of research confirms what they already know in people with type 2 diabetes and extends their knowledge in those with type 1 diabetes.

Davies added that it also confirms the significance of hypoglycaemia and the link with an increased risk of cardiovascular events, a risk that persists over a long time period, and going forward they need to focus on management strategies that help patients minimise their risk of having hypoglycaemic events.

The findings of this investigation are a stark reminder of the challenges facing patients with diabetes and could lead to changes in the management of insulin-treated patients, particularly those at high risk of cardiovascular events.

The study is published online in the journal Diabetes Care on December 9.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 13 2014 | 10:22 AM IST

Next Story